Geographic Poverty and Racial/Ethnic Disparities in Cervical Cancer Precursor Rates in Connecticut, 2008–2009

Niccolai, Linda M.; Julian, Pamela J.; Bilinski, Alyssa; Mehta, Niti R.; Meek, James; Zelterman, Daniel; Hadler, James L.; Sosa, Lynn

doi:10.2105/ajph.2011.300447

Cited by 29 publications

(29 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This clinic serves a predominantly low-income, racial and ethnic minority population. This study focused on this population to address health disparities in HPV-associated disease: racial/ethnic minority women are more likely to be infected with HPV, [12] have high-grade cervical lesions, [13] and have higher rates of cervical cancer [14,15]. …”

Section: Methodsmentioning

confidence: 99%

“It All Depends”: A Qualitative Study of Parents’ Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11–12 years

et al. 2015

Self Cite

View full text Add to dashboard Cite

Routine vaccination with three doses of human papillomavirus (HPV) vaccine is recommended for adolescent girls and boys at 11 or 12 years of age; however, vaccine uptake remains suboptimal. To understand the reasons why parents may accept or refuse HPV vaccine for their children at age 11 or 12 years, we conducted a qualitative study. Semi-structured interviews were conducted with parents or guardians (n=45) whose adolescents receive care at an urban, hospital-based primary care practice. Data were analyzed using an iterative thematic approach. We found that many parents expressed high levels of support for HPV vaccine, including a majority who agreed with vaccination at age 11-12 years. Parents recognized that for prevention of consequences of HPV infection, vaccination of their child early in adolescence was desirable conceptually. However, many parents also expressed that in practice, HPV vaccine should be given to adolescents at the onset of sexual activity, a perception that led to preferences to delay administration of HPV vaccine among certain parents. These apparently contradictory views indicate the need for interventions focused on the benefits of vaccination at the recommended ages. Our findings may be useful in providers' discussions with parents about the vaccine, as pediatric and adolescent health care providers have the unique opportunity to educate parents and clarify misconceptions about vaccination.

show abstract

Section: Methodsmentioning

confidence: 99%

“It All Depends”: A Qualitative Study of Parents’ Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11–12 years

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…To facilitate implementation of this surveillance system in Connecticut, the Department of Public Health added CIN2 þ /AIS (subsequently referred to as high-grade cervical lesions) to the list of mandatory reportable diseases, effective January 1, 2008; this system has been previously described (20). Briefly, all 34 pathology laboratories in the state are currently in compliance with the reporting requirement.…”

Section: Methodsmentioning

confidence: 99%

Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011

Niccolai

Julian

Meek

et al. 2013

Cancer Epidemiology, Biomarkers &Amp; Prevention

Self Cite

View full text Add to dashboard Cite

show abstract

“…Methods have been previously reported. 22,23 Briefly, at the Connecticut site, statewide reporting of cervical intraepithelial neoplasia grade 2 or 2/3 or 3 and adenocarcinoma in situ (CIN2/3/ AIS) is mandated by the state health department for public health surveillance, and all 34 pathology laboratories in the state are currently in compliance with this requirement. Reports include diagnostic and patient demographic information.…”

Section: Surveillance System and Individual Measuresmentioning

confidence: 99%

“…We initially considered 4 levels for the area-based measures of race, ethnicity, and poverty: < 5.0%, 5.0% to 9.9%, 10.0% to 19.9%, and 20% based on previous work. 21,23 However, due to small sample sizes in some cells for the analysis of interaction effects (described below), the lower 3 categories were combined so the final analysis included levels of <20% and 20%.…”

Section: Geocoding and Geographic Measuresmentioning

confidence: 99%

Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions

Niccolai¹,

Russ²,

Julian³

et al. 2013

Cancer

Self Cite

View full text Add to dashboard Cite

BACKGROUND: Current vaccines protect against 2 human papillomavirus (HPV) types, HPV 16 and 18, which are associated with 70% of cervical cancers and 50% of high-grade cervical lesions. HPV type distribution was examined among women with high-grade lesions by individual and area-based measures of race, ethnicity, and poverty. METHODS: This analysis included 832 women aged 18 to 39 years reported to a surveillance registry in Connecticut during 2008 to 2010. Diagnostic specimens were obtained for HPV DNA testing. Individual measures were obtained from surveillance reports, medical records, and patient interviews. Cases were geocoded to census tracts and linked to area-based measures of race, ethnicity, and poverty. Statistical analysis included use of generalized estimating equations. RESULTS: Overall, 44.8% of women had HPV 16/18. In a multivariate model controlled for confounding by age and diagnosis grade, black race (adjusted prevalence ratio

show abstract

Geographic Poverty and Racial/Ethnic Disparities in Cervical Cancer Precursor Rates in Connecticut, 2008–2009

Abstract: Disparities in cervical cancer precursors exist for poverty and race, but these effects are age dependent. This information is necessary to monitor human papillomavirus vaccine impact and target vaccination strategies.

Cited by 29 publications

References 40 publications

“It All Depends”: A Qualitative Study of Parents’ Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11–12 years

“It All Depends”: A Qualitative Study of Parents’ Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11–12 years

Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011

Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions

Contact Info

Product

Resources

About